• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将公共移码肽的潜力框定为结肠癌免疫治疗靶点。

Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer.

机构信息

Dept. of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Dept. of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Infection & Immunity, Amsterdam, The Netherlands.

出版信息

PLoS One. 2021 Jun 28;16(6):e0251630. doi: 10.1371/journal.pone.0251630. eCollection 2021.

DOI:10.1371/journal.pone.0251630
PMID:34181673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8238217/
Abstract

Approximately 15% of Colon Cancers are Microsatellite Instable (MSI). Frameshift Peptides (FPs) formed in MSI Colon Cancer are potential targets for immunotherapeutic strategies. Here we comprehensively characterize the mutational landscape of 71 MSI Colon Cancer patients from the cancer genome atlas (TCGA). We confirm that the mutations in MSI Colon Cancers are frequently frameshift deletions (23% in MSI; 1% in microsatellite stable), We find that these mutations cluster at specific locations in the genome which are mutated in up to 41% of the patients. We filter these for an adequate variant allele frequency, a sufficient mean mRNA level and the formation of a Super Neo Open Reading Frame (SNORF). Finally, we check the influence of Nonsense Mediated Decay (MMD) by comparing RNA and DNA sequencing results. Thereby we identify a set of 20 NMD-escaping Public FPs (PFPs) that cover over 90% of MSI Colon, 62.2% of MSI Endometrial and 58.8% of MSI Stomach cancer patients and 3 out of 4 Lynch patients in the TCGA-COAD. This underlines the potential for PFP directed immunotherapy, both in a therapeutic and a prophylactic setting in multiple types of MSI cancers.

摘要

约 15%的结肠癌为微卫星不稳定型(MSI)。MSI 结肠癌中形成的移码肽(FP)是免疫治疗策略的潜在靶点。在这里,我们全面描述了来自癌症基因组图谱(TCGA)的 71 例 MSI 结肠癌患者的突变景观。我们证实,MSI 结肠癌中的突变通常是移码缺失(MSI 中为 23%,微卫星稳定中为 1%)。我们发现这些突变聚集在基因组的特定位置,在多达 41%的患者中发生突变。我们对这些突变进行了适当的变异等位基因频率、足够的平均 mRNA 水平和超新开放阅读框(SNORF)的形成过滤。最后,我们通过比较 RNA 和 DNA 测序结果来检查无义介导的衰变(NMD)的影响。因此,我们确定了一组 20 个 NMD 逃逸的公共 FP(PFPs),它们覆盖了超过 90%的 MSI 结肠癌、62.2%的 MSI 子宫内膜癌和 58.8%的 MSI 胃癌患者,以及 TCGA-COAD 中 4 个 Lynch 患者中的 3 个。这强调了 FP 指导的免疫治疗的潜力,无论是在多种类型的 MSI 癌症的治疗还是预防环境中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/97c320ee94fe/pone.0251630.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/a4b96077c2f5/pone.0251630.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/bf3bfb196aef/pone.0251630.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/55ab8e33394c/pone.0251630.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/18c9b49f105b/pone.0251630.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/97c320ee94fe/pone.0251630.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/a4b96077c2f5/pone.0251630.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/bf3bfb196aef/pone.0251630.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/55ab8e33394c/pone.0251630.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/18c9b49f105b/pone.0251630.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3926/8238217/97c320ee94fe/pone.0251630.g005.jpg

相似文献

1
Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer.将公共移码肽的潜力框定为结肠癌免疫治疗靶点。
PLoS One. 2021 Jun 28;16(6):e0251630. doi: 10.1371/journal.pone.0251630. eCollection 2021.
2
Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability.无义介导的衰变抗性突变是具有微卫星不稳定性的结肠癌细胞系中表达突变蛋白的一个来源。
PLoS One. 2010 Dec 31;5(12):e16012. doi: 10.1371/journal.pone.0016012.
3
Identification of frequently mutated genes with relevance to nonsense mediated mRNA decay in the high microsatellite instability cancers.高微卫星不稳定性癌症中与无义介导的 mRNA 衰变相关的频繁突变基因的鉴定。
Int J Cancer. 2011 Jun 15;128(12):2872-80. doi: 10.1002/ijc.25641. Epub 2010 Oct 26.
4
Opportunities for immunotherapy in microsatellite instable colorectal cancer.微卫星不稳定型结直肠癌的免疫治疗机会
Cancer Immunol Immunother. 2016 Oct;65(10):1249-59. doi: 10.1007/s00262-016-1832-7. Epub 2016 Apr 8.
5
Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.微卫星不稳定的结肠癌中移码突变肽的肿瘤特异性免疫识别
Cancer Res. 2003 Sep 1;63(17):5564-72.
6
High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint.微卫星不稳定结直肠癌细胞中 TTK 突变的高频性及其对纺锤体组装检查点的影响的评估。
Carcinogenesis. 2011 Mar;32(3):305-11. doi: 10.1093/carcin/bgq272. Epub 2010 Dec 16.
7
Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability.MECOM基因移码突变的肿瘤内异质性在微卫星高度不稳定的结直肠癌中很常见。
Pathol Oncol Res. 2017 Jan;23(1):145-149. doi: 10.1007/s12253-016-0112-3. Epub 2016 Sep 13.
8
Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.胃癌和结直肠癌中TAF1和TAF1L基因单核苷酸重复序列的移码突变及其区域异质性
Pathol Oncol Res. 2017 Jan;23(1):125-130. doi: 10.1007/s12253-016-0107-0. Epub 2016 Aug 29.
9
Frameshift mutations in the MBD4/MED1 gene in primary gastric cancer with high-frequency microsatellite instability.高频微卫星不稳定的原发性胃癌中MBD4/MED1基因的移码突变
Cancer Lett. 2002 Jul 8;181(1):115-20. doi: 10.1016/s0304-3835(02)00043-5.
10
Regional Bias of Intratumoral Genetic Heterogeneity of Apoptosis-Related Genes BAX, APAF1, and FLASH in Colon Cancers with High Microsatellite Instability.高微卫星不稳定性结肠癌中凋亡相关基因BAX、APAF1和FLASH的肿瘤内遗传异质性的区域偏倚
Dig Dis Sci. 2015 Jun;60(6):1674-9. doi: 10.1007/s10620-014-3499-2. Epub 2015 Jan 20.

引用本文的文献

1
Identification of shared neoantigens derived from frameshift mutations in the gene.鉴定该基因中由移码突变产生的共享新抗原。
Front Immunol. 2025 May 15;16:1574955. doi: 10.3389/fimmu.2025.1574955. eCollection 2025.
2
The importance of protein domain mutations in cancer therapy.蛋白质结构域突变在癌症治疗中的重要性。
Heliyon. 2024 Mar 9;10(6):e27655. doi: 10.1016/j.heliyon.2024.e27655. eCollection 2024 Mar 30.
3
Neoantigens: promising targets for cancer therapy.肿瘤新抗原:癌症治疗的有前途的靶点。

本文引用的文献

1
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution.微卫星不稳定癌症的共享移码突变景观表明肿瘤进化过程中的免疫编辑。
Nat Commun. 2020 Sep 21;11(1):4740. doi: 10.1038/s41467-020-18514-5.
2
Role of POLE and POLD1 in familial cancer.POLE 和 POLD1 在家族性癌症中的作用。
Genet Med. 2020 Dec;22(12):2089-2100. doi: 10.1038/s41436-020-0922-2. Epub 2020 Aug 14.
3
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.逃避免疫原性降解与抗肿瘤免疫原性有关。
Signal Transduct Target Ther. 2023 Jan 6;8(1):9. doi: 10.1038/s41392-022-01270-x.
4
Splicing Variants, Protein-Protein Interactions, and Drug Targeting in Hutchinson-Gilford Progeria Syndrome and Small Cell Lung Cancer.剪接变异、蛋白-蛋白相互作用以及亨廷顿氏舞蹈症和小细胞肺癌的药物靶点。
Genes (Basel). 2022 Jan 18;13(2):165. doi: 10.3390/genes13020165.
5
NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes.5-氮杂胞苷对NMD的抑制增强了免疫原性移码衍生新表位的呈递。
iScience. 2021 Apr 1;24(4):102389. doi: 10.1016/j.isci.2021.102389. eCollection 2021 Apr 23.
Nat Commun. 2020 Jul 30;11(1):3800. doi: 10.1038/s41467-020-17526-5.
4
MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis.微卫星不稳定性状态与BRAF突变型结直肠癌的不同临床病理特征相关:一项系统评价和荟萃分析。
Pathol Res Pract. 2020 Jan;216(1):152791. doi: 10.1016/j.prp.2019.152791. Epub 2019 Dec 17.
5
The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy.无义介导的 mRNA 衰变对遗传疾病、基因编辑和癌症免疫治疗的影响。
Nat Genet. 2019 Nov;51(11):1645-1651. doi: 10.1038/s41588-019-0517-5. Epub 2019 Oct 28.
6
MHC-II neoantigens shape tumour immunity and response to immunotherapy.MHC-II 新抗原塑造肿瘤免疫和对免疫治疗的反应。
Nature. 2019 Oct;574(7780):696-701. doi: 10.1038/s41586-019-1671-8. Epub 2019 Oct 23.
7
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.错配修复缺陷肿瘤的遗传多样性影响抗 PD-1 免疫治疗反应。
Science. 2019 May 3;364(6439):485-491. doi: 10.1126/science.aau0447.
8
Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC-Peptide Binding Data Set.基于实验验证的 MHC-肽结合数据集的 MHC 类 I 结合预测工具的性能评估。
Cancer Immunol Res. 2019 May;7(5):719-736. doi: 10.1158/2326-6066.CIR-18-0584. Epub 2019 Mar 22.
9
MSIpred: a python package for tumor microsatellite instability classification from tumor mutation annotation data using a support vector machine.MSIpred:一个使用支持向量机从肿瘤突变注释数据中进行肿瘤微卫星不稳定性分类的 Python 包。
Sci Rep. 2018 Dec 3;8(1):17546. doi: 10.1038/s41598-018-35682-z.
10
Ensembl 2018.Ensembl 2018.
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761. doi: 10.1093/nar/gkx1098.